Switch theme
Sign up to access all valuation multiples
Dr.Finance SA is a provider of financial advisory services. The company offers advisory services for mortgages, cash loans, car loans, investments, working capital loans, investment loans, leasing, factoring, among others.
2008
2
Last FY Revenue $1.6M
Last FY EBITDA -$11K
$0.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Dr.Finance achieved revenue of $1.6M and an EBITDA of -$11K.
Dr.Finance expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Dr.Finance valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $1.6M | XXX | XXX | XXX |
| Gross Profit | XXX | $1.6M | XXX | XXX | XXX |
| Gross Margin | XXX | 96% | XXX | XXX | XXX |
| EBITDA | XXX | -$11K | XXX | XXX | XXX |
| EBITDA Margin | XXX | -1% | XXX | XXX | XXX |
| EBIT | XXX | -$12K | XXX | XXX | XXX |
| EBIT Margin | XXX | -1% | XXX | XXX | XXX |
| Net Profit | XXX | -$6K | XXX | XXX | XXX |
| Net Margin | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Dr.Finance's stock price is PLN 1 (or $0).
Dr.Finance has current market cap of PLN 2.1M (or $0.6M), and EV of PLN 1.9M (or $0.5M).
See Dr.Finance trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $0.5M | $0.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Dr.Finance has market cap of $0.6M and EV of $0.5M.
Dr.Finance's trades at 0.3x EV/Revenue multiple, and -46.6x EV/EBITDA.
Equity research analysts estimate Dr.Finance's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr.Finance's P/E ratio is not available.
See valuation multiples for Dr.Finance and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $0.6M | XXX | $0.6M | XXX | XXX | XXX |
| EV (current) | $0.5M | XXX | $0.5M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -46.6x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -42.1x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -90.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -10.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDr.Finance's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.8M for the same period.
Dr.Finance's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr.Finance's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Dr.Finance and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -1% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 97% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Credit Clear | XXX | XXX | XXX | XXX | XXX | XXX |
| Humm Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Liberty Financial Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Latitude Financial Services | XXX | XXX | XXX | XXX | XXX | XXX |
| MoneyMe | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr.Finance acquired XXX companies to date.
Last acquisition by Dr.Finance was XXXXXXXX, XXXXX XXXXX XXXXXX . Dr.Finance acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Dr.Finance founded? | Dr.Finance was founded in 2008. |
| Where is Dr.Finance headquartered? | Dr.Finance is headquartered in Poland. |
| How many employees does Dr.Finance have? | As of today, Dr.Finance has 2 employees. |
| Is Dr.Finance publicy listed? | Yes, Dr.Finance is a public company listed on WAR. |
| What is the stock symbol of Dr.Finance? | Dr.Finance trades under DRF ticker. |
| When did Dr.Finance go public? | Dr.Finance went public in 2008. |
| Who are competitors of Dr.Finance? | Similar companies to Dr.Finance include e.g. Credit Clear, Humm Group, Liberty Financial Group, Latitude Financial Services. |
| What is the current market cap of Dr.Finance? | Dr.Finance's current market cap is $0.6M |
| Is Dr.Finance profitable? | Yes, Dr.Finance is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
